Phospho-NCF1 (S328) Antibody

Shipped with Ice Packs
In Stock

Description

Mechanism of Action

The antibody binds specifically to NCF1 when phosphorylated at Ser328, a modification induced by PRKCD (Protein Kinase C Delta) . This phosphorylation activates NCF1, enabling its interaction with the NADPH oxidase complex (composed of CYBA, CYBB, and regulatory subunits like NCF2 and NCF4). The complex generates reactive oxygen species (ROS) critical for immune cell function, such as phagocytic killing of pathogens .

3.1. Immunofluorescence (IF/ICC)

  • Detects phosphorylated NCF1 in neutrophils and macrophages during oxidative burst activity .

  • Useful for studying immune cell activation in inflammation models .

3.2. Western Blot (WB)

  • Validates phosphorylation-dependent activation of NCF1 in cell lysates .

  • Requires denaturing conditions to resolve the 45–47 kDa protein .

3.3. ELISA

  • Quantifies phosphorylated NCF1 levels in cellular extracts, aiding biomarker studies for CGD .

Research Insights

  • Role in CGD: Mutations in NCF1 impair phosphorylation at Ser328, leading to ROS production defects .

  • Inflammatory Pathways: NCF1 interacts with TRAF4 and ADAM15, linking oxidative signaling to immune modulation .

  • Therapeutic Targets: Inhibitors of PRKCD or NCF1 phosphorylation are under investigation for chronic inflammation .

Critical Considerations

  • Specificity: The antibody discriminates between phosphorylated and unphosphorylated NCF1, ensuring accurate detection .

  • Optimization: Dilutions must be tailored to experimental conditions (e.g., IF: 1:200–1:500; ELISA: 1:20,000–1:40,000) .

  • Cross-Reactivity: No reported cross-reactivity with other proteins .

Product Specs

Buffer
The antibody is provided as a liquid solution in phosphate-buffered saline (PBS) containing 50% glycerol, 0.5% bovine serum albumin (BSA), and 0.02% sodium azide.
Form
Liquid
Lead Time
Typically, we can ship the products within 1-3 business days after receiving your order. The delivery time may vary depending on the shipping method and destination. For specific delivery timelines, please consult your local distributors.
Synonyms
47 kDa autosomal chronic granulomatous disease protein antibody; 47 kDa neutrophil oxidase factor antibody; NADPH oxidase organizer 2 antibody; NCF 47K antibody; NCF-1 antibody; NCF-47K antibody; Ncf1 antibody; NCF1_HUMAN antibody; Neutrophil cytosol factor 1 antibody; Neutrophil cytosolic factor 1 antibody; neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1) antibody; Neutrophil NADPH oxidase factor 1 antibody; Nox organizer 2 antibody; Nox organizing protein 2 antibody; Nox-organizing protein 2 antibody; NOXO2 antibody; p47 phox antibody; p47-phox antibody; SH3 and PX domain containing protein 1A antibody; SH3 and PX domain-containing protein 1A antibody; SH3PXD1A antibody
Target Names
Uniprot No.

Target Background

Function
NCF2, NCF1, and a membrane-bound cytochrome b558 are essential for activating the latent NADPH oxidase, which is crucial for superoxide production.
Gene References Into Functions
  1. IL-27 enhances the potential of reactive oxygen species generation from monocyte-derived macrophages and dendritic cells by inducing the expression of p47(phox). PMID: 28240310
  2. p47phox, but not p67phox or p40phox, binds to and activates Nrf2, thereby enhancing Nrf2's function in suppressing inflammation. PMID: 28939422
  3. S-glutathionylation of p47phox plays a crucial role in the sustained production of reactive oxygen species by human neutrophils. PMID: 29195919
  4. Patients with hereditary p47phox deficiency exhibit reduced platelet activation, suggesting a role for this cytosolic subunit of Nox in platelet activation. PMID: 27723093
  5. Decreased and increased copy numbers of NCF1 predispose to and protect against systemic lupus erythematosus (SLE), respectively. PMID: 28135245
  6. Lysophosphatidylcholines prime polymorphonuclear neutrophils through Hck-dependent activation of PKCdelta, which in turn stimulates PKCgamma, leading to translocation of phosphorylated p47(phox). PMID: 27531930
  7. There is an increased frequency of the NCF1-339 T allele in patients with systemic lupus erythematosus. This allele reduces extracellular ROS production in neutrophils and leads to an increase in the expression of type 1 interferon-regulated genes. PMID: 28606963
  8. Skeletal muscle protein expression of the NADPH oxidase subunits p22(phox), p47(phox), and p67(phox) is increased in obese individuals compared to lean subjects. Exercise training in obese subjects attenuates the expression of p22(phox) and p67(phox). PMID: 27765769
  9. A novel role for Spns2 and S1P1&2 in the activation of p47(phox) and production of reactive oxygen species involved in hyperoxia-mediated lung injury has been identified. PMID: 27343196
  10. This study provides evidence for a novel PKC-zeta to p47phox interaction that is required for cell transformation from blebbishields and ROS production in cancer cells. PMID: 27040869
  11. Overexpression of p47phox is associated with an increased migration and metastasis rate in melanoma. PMID: 26760964
  12. A rare mutation in NCF1 encoding p47phox of the leukocyte NADPH oxidase causes a lack of superoxide generation, leading to chronic granulomatous disease. This mutation was recently introduced (1200-2300 years ago) into the Kavkazi Jewish population. PMID: 26460255
  13. Data show that diphenylene iodonium (DPI) and apocynin can reduce hyperoxia-induced reactive oxygen species (ROS) production by decreasing the translocation and level of NADPH Oxidase p47phox. PMID: 26728380
  14. Increased levels of gp91phox, p47phox, and p22phox likely account for the interferon-gamma-mediated enhancement of dimethyl sulfoxide-induced Nox2 activity. PMID: 26317224
  15. This research identifies p47phox-dependent NADPH oxidase activity as a critical component of Angpt-1-mediated endothelial barrier defense against classic inflammatory permeability factors. PMID: 25761062
  16. Mutations in DCLRE1C and NCF1 have been found by whole-genome sequencing to cause primary immunodeficiency in unrelated patients. PMID: 25981738
  17. TLR8, but not TLR7, is involved in priming human neutrophil reactive oxygen species production by inducing the phosphorylation of p47phox and p38 MAPK. PMID: 25877926
  18. Reduced carotid but not coronary artery atherosclerosis in patients with chronic granulomatous disease, despite the high prevalence of traditional risk factors, raises questions about the role of NADPH oxidase in the pathogenesis of atherosclerosis. PMID: 25239440
  19. Four novel mutations in the NCF1, NCF2, and CYBB genes have been identified in chronic granulomatous disease patients in Morocco. PMID: 24596025
  20. This study suggests that eupafolin attenuated COX-2 expression, leading to reduced production of prostaglandin E2 by blocking the Nox2/p47(phox) pathway. PMID: 24967690
  21. p47(phox) and Rac2 accumulate only transiently at the phagosome at the onset of NADPH activity and detach from the phagosome before the end of reactive oxygen species production. PMID: 23870057
  22. There was an increase in p47-phox phosphorylation in neutrophils from myeloproliferative disorder patients with the JAK2 (V617F) mutation. PMID: 23975181
  23. Two novel mutations have been identified in Greek patients with chronic granulomatous disease: one in NCF1 and one in cytochrome CYBB. PMID: 24081483
  24. Williams syndrome patients are at risk for increased aortic stiffness. This vascular stiffness is caused by elastin insufficiency and is modified by NCF1 copy number. PMID: 24126171
  25. Data show that curcumin-loaded polyvinylpyrrolidone nanoparticles (CURN) decreased the expression of ICAM-1, inhibited NADPH oxidase (NOX)-derived ROS generation, and reduced MAPKs and AP-1 transcription factor binding activities. PMID: 23671702
  26. This study identified a 10% incidence of diabetes in p47 (phox) deficient chronic granulomatous disease (CGD), but none in X-linked CGD. PMID: 23386289
  27. Three different cross-over points exist within the NCF1 gene cluster, indicating that autosomal p47(phox)-deficient CGD is genetically heterogeneous but can be dissected in detail by MLPA. PMID: 23688784
  28. Patients with p47(phox) hereditary deficiency have intermediate flow-mediated dilation and oxidative stress compared to healthy subjects and patients with NOX2 deficiency. PMID: 23216310
  29. Defining p47-phox deficient Chronic Granulomatous Disease in a Malay family. PMID: 23393912
  30. Resveratrol decreases hyperglycemic-induced superoxide production via up-regulation of SIRT1, induction of FOXO3a, and inhibition of p47phox in monocytes. PMID: 21813271
  31. There is no correlation between the C923T(Ala308Val) polymorphism and cerebral hemorrhage in Han people in Hunan province. PMID: 21566280
  32. The low affinity and selectivity of the atypical phosphoinositide-binding site on the p47(phox) PX domain suggest that different types of phosphoinositides sequentially bind to the p47(phox) PX domain. PMID: 22493288
  33. Phosphorylation of p47(phox) at different serine sites plays distinct roles in endothelial cell response to TNFalpha stimulation. PMID: 22460559
  34. A diffuse cytosolic distribution of p47-phox was observed in neutrophils from HIV-infected patients. PMID: 22690528
  35. MLCK is essential for the translocation and association of cortactin and p47phox. PMID: 22219181
  36. An increased copy number of NCF1 may be protective against developing rheumatoid arthritis (RA) and supports previous findings regarding the role of NCF1 and the phagocyte NADPH oxidase complex in RA pathogenesis. PMID: 21728841
  37. Autosomal recessive mutational defects are the predominant subtype in Iranian patients with chronic granulomatous disease. PMID: 21789723
  38. Cooperation of p40(phox) with p47(phox) for Nox2-based NADPH oxidase activation during Fcgamma receptor (FcgammaR)-mediated phagocytosis. PMID: 21956105
  39. Data implicate p47phox as one of the sources of oxidative stress in diabetic islets or beta cells during hyperglycemia. Evidence supports an accelerated Rac1-Nox-ROS-JNK1/2 signaling pathway leading to mitochondrial dysregulation. PMID: 21911753
  40. Protein disulfide isomerase redox-dependent association with p47(phox): evidence for an organizer role in leukocyte NADPH oxidase activation. PMID: 21791598
  41. Results demonstrate that PBEF can prime for PMN respiratory burst activity by promoting p40 and p47 translocation to the membrane. PMID: 21518975
  42. Direct contact of solid tumor cells and endothelial cells (ECs) activates endothelial NAD(P)H oxidase-mediated superoxide production. The oxidative stress contributes to EC apoptosis, which in turn facilitates tumor cell extravasation. PMID: 21506107
  43. A differential and agonist-dependent role of the p47(phox) PX domain for neutrophil NADPH oxidase activation. PMID: 20817944
  44. Granulomatous disease in Iran is predominantly due to mutations in p47-phox, while the number of mutations in p22-phox is roughly equal to that in gp91-phox, indicating that the genetics of CGD are ethnically variable. PMID: 20407811
  45. Loss of p47phox is associated with inflammasome activation resulting in chronic granulomatous disease. PMID: 20495074
  46. p47phox molecular activation for assembly of the neutrophil NADPH oxidase complex. PMID: 20592030
  47. Mutations in CYBB, NCF1, CYBA, or NCF2 may play a role in chronic granulomatous disease. PMID: 18546332
  48. There is an increased expression of NADPH oxidase p47(-PHOX) and p67(-PHOX) factor in idiopathic pulmonary fibrosis patients. PMID: 17651608
  49. All mutations and some polymorphisms identified in the NCF1 gene in the autosomal forms of chronic granulomatous disease are listed. Review. PMID: 20167518
  50. Expression of the p47phox subunit and NOX activity was evaluated in affected (superior and middle temporal gyri) and unaffected (cerebellum) brain regions from a longitudinally followed group of patients with varying degrees of cognitive impairment. PMID: 19929442

Show More

Hide All

Database Links

HGNC: 7660

OMIM: 233700

KEGG: hsa:653361

STRING: 9606.ENSP00000289473

UniGene: Hs.647047

Involvement In Disease
Granulomatous disease, chronic, cytochrome-b-positive 1, autosomal recessive (CGD1)
Subcellular Location
Cytoplasm, cytosol. Membrane; Peripheral membrane protein; Cytoplasmic side.
Tissue Specificity
Detected in peripheral blood monocytes and neutrophils (at protein level).

Q&A

What is NCF1/p47-phox and what is its biological significance?

NCF1 (Neutrophil Cytosol Factor 1), also known as p47-phox, is a 47 kDa cytosolic component of the NADPH oxidase complex. It functions as an organizer protein (NOXO2) that, together with NCF2 and membrane-bound cytochrome b558, is required for activation of the latent NADPH oxidase, which is necessary for superoxide production . NCF1 is primarily detected in peripheral blood monocytes and neutrophils at the protein level . Mutations in NCF1 are associated with chronic granulomatous disease, an immunodeficiency characterized by severe recurrent bacterial and fungal infections due to impaired phagocyte function .

The protein contains several functional domains including SH3 domains and a PX domain that mediates interaction with phosphatidylinositol 3,4-bisphosphate and other anionic phospholipids . In its unphosphorylated state, NCF1 exists in an autoinhibited conformation where intramolecular interactions prevent lipid binding and interaction with other components .

Why is phosphorylation at Ser328 specifically important?

Phosphorylation at Ser328 is a critical post-translational modification that disrupts the autoinhibited state of NCF1 . This phosphorylation event is primarily mediated by Protein Kinase C delta (PKCδ) and directly induces activation of NCF1 and subsequent NADPH oxidase activity . The modification enables NCF1 to translocate from the cytosol to the membrane, where it can interact with other components of the NADPH oxidase complex to facilitate superoxide production.

Research has shown that the phosphorylation state of Ser328 serves as a direct indicator of NCF1 activation status in various experimental systems, making antibodies specific to this modification valuable tools for studying NADPH oxidase regulation .

What applications can Phospho-NCF1 (S328) Antibody be used for?

Based on product specifications from multiple suppliers, Phospho-NCF1 (S328) Antibody can be utilized in various research applications:

ApplicationRecommended DilutionNotes
Western Blot (WB)1:500-1:2000For detection of denatured protein samples
Immunohistochemistry (IHC)1:100-1:300For paraffin sections (IHC-p) or frozen sections (IHC-f)
Immunofluorescence (IF/ICC)1:50-1:200For cellular immunofluorescence detection
ELISA1:10000For detecting antigenic peptides

The antibody specifically detects endogenous levels of p47-phox protein only when phosphorylated at S328, making it ideal for studying the activation state of NADPH oxidase in various cell types and experimental conditions .

How does phosphorylation at Ser328 compare with other phosphorylation sites on NCF1?

NCF1 undergoes phosphorylation at multiple sites during activation, with Ser328 and Ser304 being two of the most well-characterized:

Phosphorylation SitePrimary KinaseFunctional SignificanceAvailable Detection Tools
Ser328PKCδDisrupts autoinhibition, facilitates membrane translocationAnti-Phospho-NCF1 (S328) antibodies
Ser304PKC/PAKConformational changes, exposure of functional domainsAnti-Phospho-NCF1 (S304) antibodies

Research shows that these phosphorylation events may occur sequentially or in concert depending on the stimulus. For example, in IL-27-induced macrophages stimulated with PMA, 2D gel electrophoresis revealed distinct patterns of phosphorylation at S304 compared to control macrophages, suggesting differential regulation of these phosphorylation sites .

The temporal and functional relationship between these phosphorylation events remains an active area of research, with evidence suggesting that they may serve complementary roles in the full activation of the NADPH oxidase complex .

What methodological approaches can optimize detection of phosphorylated NCF1 (Ser328)?

Detection of phosphorylated NCF1 requires careful consideration of experimental conditions:

  • Cell stimulation protocols:

    • PMA treatment (100 ng/ml for 30 minutes at 37°C) is commonly used to induce maximal phosphorylation

    • For macrophage differentiation, 50nM PMA for 24 hours is an established protocol

  • Sample preparation considerations:

    • Rapid sample processing with phosphatase inhibitors is critical to preserve phosphorylation status

    • For Western blotting, recommended dilutions range from 1:500-1:2000

    • For immunohistochemistry, antigen retrieval methods must be optimized to expose the phospho-epitope without destroying it

  • Validation approaches:

    • Use of synthesized phosphopeptide blocking controls can confirm specificity

    • Two-dimensional gel electrophoresis can help separate phosphorylated from non-phosphorylated forms

    • Phosphatase treatment of sample aliquots can serve as negative controls

The most reliable results are obtained when multiple detection methods are used in combination with appropriate controls .

How can researchers distinguish between phosphorylated and non-phosphorylated forms in complex samples?

Several techniques can be employed to distinguish phosphorylated from non-phosphorylated NCF1:

  • Two-dimensional gel electrophoresis:

    • This technique separates proteins by both isoelectric point and molecular weight

    • Phosphorylated NCF1 shows a characteristic shift toward more acidic pH

    • Detection with both anti-phospho-NCF1 and total NCF1 antibodies on parallel samples confirms phosphorylation status

  • Peptide competition assays:

    • Pre-incubating the antibody with its immunizing phosphopeptide should abolish specific staining

    • This has been demonstrated with commercial antibodies like ab111855, where peptide treatment eliminated staining in human lymph node tissue

  • Mass spectrometry approaches:

    • LC-MS/MS analysis after phosphopeptide enrichment can identify specific phosphorylation sites

    • This technique has been used for phosphoproteome analysis in studies using PMA-treated macrophages

    • High-resolution mass spectrometry (e.g., Orbitrap fusion) coupled with appropriate separation techniques allows precise identification of phosphorylation sites

  • Phosphatase treatment controls:

    • Treating sample aliquots with lambda phosphatase should eliminate phospho-specific signal while preserving total NCF1 detection

These complementary approaches provide robust verification of phosphorylation status in complex biological samples .

What is the relationship between NCF1 phosphorylation at Ser328 and NADPH oxidase assembly?

The sequence of events linking NCF1 phosphorylation to NADPH oxidase activation follows a well-established pattern:

  • In resting cells, NCF1 exists in an autoinhibited conformation where intramolecular interactions prevent binding to membrane components

  • Upon cell stimulation (e.g., with PMA), PKCδ phosphorylates NCF1 at Ser328

  • This phosphorylation disrupts the autoinhibitory conformation, enabling:

    • Exposure of the PX domain for membrane phospholipid interaction

    • Liberation of SH3 domains to interact with p22-phox

    • Translocation of NCF1 from cytosol to membrane

  • At the membrane, phosphorylated NCF1 facilitates the assembly of other cytosolic components (NCF2, p40-phox) with membrane-bound elements (gp91-phox, p22-phox)

  • The fully assembled complex then enables electron transfer from NADPH to molecular oxygen, generating superoxide

This process is evident in experimental systems where increased phosphorylation at Ser328 correlates directly with enhanced reactive oxygen species production, particularly in neutrophils and macrophages responding to inflammatory stimuli .

What controls are essential when studying NCF1 phosphorylation in disease models?

Robust experimental design for studying NCF1 phosphorylation in disease contexts should include:

  • Positive controls:

    • PMA-stimulated neutrophils or macrophages to demonstrate maximal phosphorylation

    • Cell lines with confirmed NCF1 expression and phosphorylation capacity

  • Negative controls:

    • Unstimulated cells showing baseline phosphorylation levels

    • Phosphatase-treated samples to confirm phospho-specificity

    • Peptide competition controls to validate antibody specificity

  • Method-specific controls:

    • For immunohistochemistry: parallel sections with primary antibody omission

    • For Western blot: loading controls and molecular weight markers

    • For phospho-flow cytometry: appropriate isotype controls and fluorescence-minus-one controls

  • Disease-specific considerations:

    • Age-matched and sex-matched controls for animal or human studies

    • Consideration of comorbidities that might affect NADPH oxidase regulation

    • Documentation of treatments that could modulate phosphorylation status

Implementation of these controls ensures reliable interpretation of NCF1 phosphorylation data in complex disease models .

How does NCF1 Ser328 phosphorylation differ across immune cell populations?

Phosphorylation patterns of NCF1 at Ser328 show distinct profiles across immune cell types:

  • Neutrophils:

    • Express high levels of NCF1

    • Demonstrate rapid phosphorylation at Ser328 following stimulation

    • Phosphorylation correlates with respiratory burst activity

  • Monocytes/Macrophages:

    • Show more sustained phosphorylation kinetics than neutrophils

    • IL-27-induced macrophages (I-Mac) exhibit increased p47-phox expression and phosphorylation compared to control macrophages (M-Mac)

    • This difference correlates with enhanced ROS production as measured by H₂O₂ release

  • Other immune cells:

    • T cells express lower levels of NCF1 and demonstrate different phosphorylation dynamics

    • Limited data exists on NCF1 phosphorylation in lymphocytes compared to myeloid cells

These cell type-specific differences must be considered when designing experiments and interpreting results across different immune cell populations .

What methodological approaches enable study of the kinetics of NCF1 Ser328 phosphorylation?

Several techniques can be employed to study the temporal dynamics of NCF1 phosphorylation:

  • Time-course Western blot analysis:

    • Samples collected at multiple time points after stimulation

    • Quantification of phospho-to-total NCF1 ratios provides relative phosphorylation kinetics

    • Recommended dilutions of 1:500-1:2000 for optimal detection

  • Phospho-flow cytometry:

    • Allows single-cell analysis of phosphorylation events

    • Can be combined with surface marker staining to examine specific cell populations

    • Requires optimization of fixation and permeabilization protocols to preserve phospho-epitopes

  • Live-cell imaging approaches:

    • Challenging due to limitations of introducing phospho-specific antibodies into live cells

    • Possible through development of biosensors based on phospho-binding domains

    • Correlative live-cell and fixed-cell imaging at defined time points

  • Mass spectrometry-based temporal profiling:

    • Enables absolute quantification of phosphorylation stoichiometry

    • Can simultaneously monitor multiple phosphorylation sites

    • Requires specialized equipment and expertise in phosphoproteomics

Each approach offers different temporal resolution and should be selected based on the specific research question and available resources .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.